Endo International PLC
NASDAQ:ENDP

  • LAST PRICE
    0.4657
  • TODAY'S CHANGE (%)
    -0.0569 (-10.8879%)
  • Bid / Lots
    0.4384/ 12
  • Ask / Lots
    0.4389/ 50
  • Open / Previous Close
    0.4045 / 0.5226
  • Day Range
    0.3600
    0.4700
  • 52 Week Range
    0.2800
    7.0652
  • Volume
    136,756,005

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Pharmaceuticals - Diversified Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
ENDP
Endo International PLC
122.9M
-0.2x
---
AMRX
Amneal Pharmaceuticals Inc
1.0B
313.0x
---
EBS
Emergent BioSolutions Inc
1.5B
10.6x
+27.49%
OPK
OPKO Health Inc
1.8B
-14.2x
---
JAZZ
Jazz Pharmaceuticals PLC
9.8B
-20.7x
---
PRGO
Perrigo Company PLC
5.5B
-40.2x
---
As of 2022-06-30

Company Information

Endo International plc is a specialty pharmaceutical company. The Company operates through four business segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. Its Branded Pharmaceuticals segment includes a variety of branded products in the areas of urology, orthopedics, endocrinology, medical aesthetics and bariatrics, among others. Its products include XIAFLEX, SUPPRELIN LA, NASCOBAL Nasal Spray, AVEED, QWO, PERCOCET, TESTOPEL, EDEX and LIDODERM, among others. Its Sterile Injectables segment consists of branded sterile injectable products such as VASOSTRICT, ADRENALIN and APLISOL, among others, and certain generic sterile injectable products, including ertapenem for injection and ephedrine sulfate injection. The Company's Generic Pharmaceuticals segment consists of a product portfolio, including solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic and sprays.

Contact Information

Headquarters
Minerva House, Simmonscourt RoadDUBLIN, Ireland 000 00
Phone
---
Fax
---

Executives

Independent Non-Executive Chairman of the Board
Mark Barberio
President, Chief Executive Officer, Director
Blaise Coleman
Chief Financial Officer, Executive Vice President
Mark Bradley
Executive Vice President, Chief Legal Officer, Company Secretary
Matthew Maletta
Executive Vice President, President, Global Commercial Operations
Patrick Barry

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$122.9M
Revenue (TTM)
$2.9B
Shares Outstanding
235.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.06
EPS
$-2.92
Book Value
$-5.32
P/E Ratio
-0.2x
Price/Sales (TTM)
0.0
Price/Cash Flow (TTM)
---
Operating Margin
-3.80%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.